Bangladesh vs Gambia: HIV-positive TB patients on ART (antiretroviral therapy)
Bangladesh
93.0%
in 2024
Gambia
93.0%
in 2024
Bangladesh rank
85th
Gambia rank
85th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bangladesh
- Gambia
How they compare
Bangladesh currently reports 93.0% against 93.0% in Gambia, a difference of 0.0%.
The two have swapped places 1 time across 15 shared years of data; in 2008 it was Bangladesh ahead.
Bangladesh ranks 85th and Gambia ranks 85th of 144 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.5% | 14.5% | 65.0% | Bangladesh |
| 2010s | 94.8% | 54.1% | 40.7% | Bangladesh |
| 2020s | 91.5% | 91.2% | 0.2% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bangladesh or Gambia?
- Bangladesh, at 93.0% against 93.0% in Gambia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bangladesh and Gambia?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Gambia?
- 15 years are reported by both, from 2008 to 2024.
- How do Bangladesh and Gambia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bangladesh ranks 85th and Gambia ranks 85th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.